Cargando…
Effect of trimetazidine on the functional capacity of ischemic heart disease patients not suitable for revascularization: Meta-analysis of randomized controlled trials
OBJECTIVE: To explore the effect of adding trimetazidine to other anti-anginal drugs on the functional capacity of ischemic heart disease (IHD) patients not suitable for revascularization when compared to first-line antianginal drugs alone. METHODS: MEDLINE and EMBASE databases were searched for Eng...
Autores principales: | Ajabnoor, Alyaa, Mukhtar, Amnah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836318/ https://www.ncbi.nlm.nih.gov/pubmed/35148340 http://dx.doi.org/10.1371/journal.pone.0263932 |
Ejemplares similares
-
Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021) -
Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross‐over trial
por: van de Bovenkamp, Arno A., et al.
Publicado: (2023) -
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients
por: El-khodary, Noha M., et al.
Publicado: (2022) -
Meta-analysis of trimetazidine treatment for cardiomyopathy
por: Fan, Qian, et al.
Publicado: (2018) -
Trimetazidine in angina and poor muscle function: protocol for a randomized controlled study
por: Zhang, Yu-Jie, et al.
Publicado: (2019)